Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06660017 · ClinicalTrials.gov registry record · Phase 2
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
A Phase 2 study, sponsored by University of Oklahoma.
- Not yet
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT06660017 is a Phase 2 study that has not yet begun recruiting, run by University of Oklahoma. The registered enrollment target is 62 participants.
The verdict
NCT06660017, a Phase 2 study, has not yet begun recruiting, sponsored by University of Oklahoma.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.
Interventions
- DRUG Placebo
- DRUG Ketamine Topical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06660017
The ClinicalTrials.gov registry entry for NCT06660017 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06660017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06660017 about?
NCT06660017 is a clinical study titled "Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse". This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.
What is the current status of trial NCT06660017?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2026-06. Estimated completion is 2027-11.
What interventions are being tested in trial NCT06660017?
The interventions under investigation include: Placebo (DRUG), Ketamine Topical (DRUG).
Who is sponsoring clinical trial NCT06660017?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.